These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 7780971)

  • 1. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
    Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
    Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
    Dole M; Nuñez G; Merchant AK; Maybaum J; Rode CK; Bloch CA; Castle VP
    Cancer Res; 1994 Jun; 54(12):3253-9. PubMed ID: 8205548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
    Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells.
    Dole MG; Clarke MF; Holman P; Benedict M; Lu J; Jasty R; Eipers P; Thompson CB; Rode C; Bloch C; Nuñez ; Castle VP
    Cancer Res; 1996 Dec; 56(24):5734-40. PubMed ID: 8971184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
    Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.
    Cinatl J; Cinatl J; Vogel JU; Kotchetkov R; Driever PH; Kabickova H; Kornhuber B; Schwabe D; Doerr HW
    Cancer Res; 1998 Jan; 58(2):367-72. PubMed ID: 9443419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis.
    Sumantran VN; Ealovega MW; Nuñez G; Clarke MF; Wicha MS
    Cancer Res; 1995 Jun; 55(12):2507-10. PubMed ID: 7780958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.
    Schmitt E; Cimoli G; Steyaert A; Bertrand R
    Exp Cell Res; 1998 Apr; 240(1):107-21. PubMed ID: 9570926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration.
    Joseph RM; Li T
    Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2434-46. PubMed ID: 8933760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
    Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
    Schmitt E; Sané AT; Steyaert A; Cimoli G; Bertrand R
    Biochem Cell Biol; 1997; 75(4):301-14. PubMed ID: 9493953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
    Fernández Y; España L; Mañas S; Fabra A; Sierra A
    Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
    Kondo S; Shinomura Y; Kanayama S; Higashimoto Y; Kiyohara T; Zushi S; Kitamura S; Ueyama H; Matsuzawa Y
    Oncogene; 1998 Nov; 17(20):2585-91. PubMed ID: 9840921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H; Bouchon A; Stahl H; Krammer PH
    Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl-2.
    Simonian PL; Grillot DA; Nuñez G
    Oncogene; 1997 Oct; 15(15):1871-5. PubMed ID: 9362454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death.
    Huang DC; Cory S; Strasser A
    Oncogene; 1997 Jan; 14(4):405-14. PubMed ID: 9053837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.